Home LiteratureArticle Details
PMID: 3683478 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion.

The New England journal of medicine ·Vol. 317 ·No. 23 ·1987-12-03 ·Pages 1444-51

Gates GA, Avery CA, Prihoda TJ, Cooper JC

Abstract

To study the effectiveness of adenoidectomy and of the placement of tympanostomy tubes in the treatment of chronic otitis media with effusion, we randomly assigned 578 children, aged four through eight years, to receive bilateral myringotomy and no additional treatment (Group 1), placement of tympanostomy tubes (Group 2), adenoidectomy (Group 3), or adenoidectomy and placement of tympanostomy tubes (Group 4). The 491 children who underwent one of these treatments were examined at six-week intervals for up to two years. The mean time spent with effusion of any type in either ear over the two-year follow-up in the four groups was 51, 36, 31, and 27 weeks, respectively (P less than 0.0001), comparing Group 1 with each of the other groups. Hearing was equivalent in Groups 2, 3, and 4, and was significantly better than in Group 1. The most frequent sequela, purulent otorrhea, occurred one or more times in 22, 29, 11, and 24 percent of the subjects in Groups 1, 2, 3, and 4, respectively (P less than 0.001). Adenoidectomy plus bilateral myringotomy lowered the overall post-treatment morbidity (as measured by hearing acuity in the most severely affected ear [P = 0.0174] and the number of surgical retreatments required [P = 0.009]) more than did tympanostomy tubes alone and to the same degree as did adenoidectomy and tympanostomy tubes. We conclude that adenoidectomy should be considered when surgical therapy is indicated in children four to eight years old who are severely affected by chronic otitis media with effusion.

MeSH Terms
Adenoidectomy Anti-Bacterial Agents/therapeutic use Child Child, Preschool Chronic Disease Female Follow-Up Studies Hearing Humans Male Middle Ear Ventilation Otitis Media with Effusion/drug therapy,physiopathology,surgery Postoperative Complications Recurrence Reoperation
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gates G A
Division of Otorhinolaryngology, University of Texas Health Science Center, San Antonio 78284-7777.
Avery C A
Prihoda T J
Cooper J C
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1987-12-03
Pages
1444-51
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NINDS NIH HHS · NS-NO-1-02328 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com